Skip to main content
SpringerLink
Log in

Hepatische Enzephalopathie

  • Conference paper
Ergebnisse der Inneren Medizin und Kinderheilkunde/Advances in Internal Medicine and Pediatrics

  • 22 Accesses

Zusammenfassung

Der Begriff „hepatische Enzephalopathie“ beschreibt alle neuropsychiatrischen Syndrome, die bei akuten oder chronischen Lebererkrankungen auftreten können. Die hepatische Enzephalopathie ist kein einheitliches Krankheitsbild, ein genaueres Verständnis ihrer Pathogenese and eine etablierte Therapie sind in weiter Ferne.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Al Mardini H, Bartlett K, Record CO (1984) Blood and brain concentrations of mercaptans in hepatic and methanethiol induced coma. Gut 25: 284–290

    PubMed  Google Scholar 

  • Bansky G, Meier PJ, Ziegler WH (1985) Révérai of hepatic coma by benzodiazepin antagonist Ro 15–1788). Lancet 1: 1324–1325

    Google Scholar 

  • Baraldi M, Zeneroli ML (1982) Experimental hepatic encephalopathy - changes in gammamino- butyric acid. Science 216: 427–431

    PubMed  CAS  Google Scholar 

  • Baraldi M, Caselgrandi E, Borella P, Zeneroli ML (1983a) Decrease of brain zinc in experimental hepatic encephalopathy. Brain Res 258: 170–172

    CAS  Google Scholar 

  • Baraldi M, Zeneroli ML, Ricci P (1983b) Down regulation of striatal dopamine receptors in experimental hepatic encephalopathy. Life Sei 32: 1417–1425

    CAS  Google Scholar 

  • Baraldi M, Zeneroli ML, Ventura E, Penne A, Pinelli G, Ricci P, Santi M (1984) Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist Clin Science 67: 167–175

    CAS  Google Scholar 

  • Bengtsson F (1987) Chronic portal-systemic encephalopathy. Thesis. Bulletin No. 66, Department of Surgery, Lund University, Lund Benjamin AM, Okamoto K, Quastel JH (1978) Effects of ammonium ions on spontaneous action potentials and on contents of sodium, potassium, assonium and chloride ions in brain in vitro. J Neurochem 30: 131–143

    Google Scholar 

  • Bianchi-Porro G, Maiolo AT, Delia-Porto P (1969) Cerebral blood flow und metabolism before and after portacaval shunt operation. Gut 10: 894–897

    PubMed  CAS  Google Scholar 

  • Binder H (1981) Die neuropsychiatrische Symptomatik des sogenannten “Coma hepaticum”. Beilage zur Wiener Klinischen Wochenschrift 93: 3–19

    Google Scholar 

  • Bircher J, Bührer M, Franz K, van Velthuijsen JA (1982) Erstmalige Anwendung von Lactitol in der Behandlung der porto-systemischen Enzephalopathie. Schweiz Med Wschr 112:1306— 1307

    Google Scholar 

  • Bockel R, Doffoel M (1981) Lavage digestif au mannitol dans les hémorragies digestives du cirrhotique. Nouv Presse Med 10: 33–36

    PubMed  CAS  Google Scholar 

  • Brunner G, Scharff P (1978) Untersuchungen über den diagnostischen Wert der Bestimmung von Mercaptanen im Serum bei Lebererkrankungen. Dtsch Med Wschr 103: 1796–1800

    PubMed  CAS  Google Scholar 

  • Cangiano C, Cardelü-Cangiano P, James JH, Rossi-Fanelli F, Patrizi MA, Brackett KA, Strom R, Fischer JE (1983) Brain microvessels take up large neutral amino acids in exchange for glutamine. Cooperative role of Na*-dependent and Na+-independent systems. J Biol Chem 258: 8949–8954

    Google Scholar 

  • Cardelli-Cangiano P, Cangiano C, James JH, Jeppsson B, Brenner W, Fischer JE (1981) Uptake of amino acids by brain microvessels isolated from rats after portacaval anastomosis. J Neuro-chem 36: 627–632

    CAS  Google Scholar 

  • Cardelli-Cangiano P, Cangiano C, James JH, Ceci F, Fischer JE, Stiom R (1984) Effect of ammonia on amino acid uptake by brain microvessels. J Biol Chem 259: 5295–5300

    PubMed  CAS  Google Scholar 

  • Cerra FB, Cheung NK, Fischer JE (1985) Disease specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. J Parent and Ent Nutr 9: 228–295

    Google Scholar 

  • Conn HO (1977) Trailmaking and number conncetion tests in the assessment of metal state in

    Google Scholar 

  • postal systemic encephalopathy. Am J Dig Dis 22:541–550

    Google Scholar 

  • Conn HO, Lieberthal MM (1979) The hepatic coma syndromes and lactulose. Williams amp; Wilkins, Baltimore Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL(1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. Gastroenterology 72: 573–583

    Google Scholar 

  • Cooper AJL, Mora SN, Cruz NF, Gelbard AS (1985) Cerebral ammonia metabolism in hyper-ammonemic rats. J Neurochem 44: 1716–1723

    PubMed  CAS  Google Scholar 

  • Cruz NF, Duffy TE (1983) Local cerebral glucose metabolism in rats with portacaval shunts. J Cerebr. Blood Flow amp; Metabol 3: 311–320

    Google Scholar 

  • Cuilleret G, Pomier-Layrargues G, Pons F, Cadilhac J, Michel H (1980) Changes in brain catecholamine levels in human cirrhotic hepatic encephalopathy. Gut 21: 565–569

    PubMed  CAS  Google Scholar 

  • Cummings MG, Soeters PB, James JH, Keane JM, Fischer JE (1976) Regional brain indoleamine metabolism following chronic portacaval anastomosis in the rat. J Neurochem 27: 501–509

    PubMed  CAS  Google Scholar 

  • De Bruijn KM, Blendis LM, Zilm DH, Carlen PL, Anderson GH (1983) Effect of dietary protein manipulations in subclinical portal-systemic encephalopathy. Gut 24: 53–60

    PubMed  Google Scholar 

  • Delorme ML, Denis J, Nordlinger B, Boschat M, Opolon P (1981) Relationship between plasma and brain tryptophan in pigs during experimental hepatic coma before and after hemodialysis with selective membranes. J Neurochem 36: 1058–1066

    PubMed  CAS  Google Scholar 

  • Ede RJ, Williams R (1986) Hepatic encephalopathy and cerebral edema. Sem in Liver Disease 6: 107–118

    CAS  Google Scholar 

  • Egberts EH, Schomerus H, Hamster W, Jürgens P (1985) Branched chain amino acids in the treatment of latent portosystemic encephalopathy. Gastroenterology 88: 887–895

    PubMed  CAS  Google Scholar 

  • Elsass P, Christensen SE, Mortensen L, Vilstrup H (1985) Discrimination between organic and hepatic encephalopathy by means of continous reaction times. Liver 5: 29–34

    PubMed  CAS  Google Scholar 

  • Enna SJ, Wood JH, Snyder SH (1977) 7-Aminobutyric acid (GABA) in human cerebrospinal fluid: radioreceptor assay. J Neurochem 28: 1121–1124

    Google Scholar 

  • Faraj BA, Bowen PA, Isaacs JW, Rudman D (1976) Hypertryraminemia in cirrhotic patients.N Engl J Med 294: 1360–1364

    CAS  Google Scholar 

  • Ferenci P (1986) Critical evaluation of the role of branched chain amino acids in liver disease. In: Thomas JC, Jones EA (eds) Recent advances in heptalogy. Churchill Livingstone Edinburgh London Melbourne New York, pp 137–154

    Google Scholar 

  • Ferenci P, Wewalka F (1978) Plasma amino acids in hepatic encephalopathy. J Neural Transmiss, Suppl 14: 87–94

    Google Scholar 

  • Ferenci P, Dragosics B, Wewalka F (1981) Oral administration of branched chain amino acids (BCAA) and keto acids (BCKA) in patients with liver cirrhosis (LC). In: Walser M, Williamson JR (eds) Metabolism and clinical implications of branched chain amino acids and ketoacids, Elsevier/North Holland, New York Amsterdam-Oxford, pp 507–512

    Google Scholar 

  • Ferenci P, Covfell D, Schafer DF, Waggoner JG, Shrager R, Jones EA (1983a) Metabolism of the inhibitory neurotransmitter 7-aminobutyric acid in a rabbit model of fulminant hepatic failure. Hepatology 3: 507–512

    PubMed  CAS  Google Scholar 

  • Ferenci P, Riederer P, Jellinger K, Schafer DF, Jones EA (1983b) Changes in 7-aminobutyric acid receptor in patients with hepatic encephalopathy. Gastroenterology 84: 1371

    Google Scholar 

  • Ferenci P, Schäfer DF, Kleinberger G (1983c) Serum levels of gamma-aminobutyric acid–like activity in acute and chronic hepatocellular disease. Lancet 11: 811–814

    Google Scholar 

  • Ferenci P, Jacobs R, Pappas SC, Schafer DF, Jones EA (1984a) Enzymes of cerebral GAB A metabolism and synaptosomal GABA uptake in acute liver failure in the rabbit: evidence for decreased cerebral GABA-transaminase activity. J Neurochem 42: 1487–1490

    PubMed  CAS  Google Scholar 

  • Ferenci P, Pappas SC, Munson PJ (1984b) Changes in the status of neurotransmitter receptors in a rabbit model of hepatic encephalopathy. Hepatology 4: 186–191

    PubMed  CAS  Google Scholar 

  • Ferenci P, Pappas SC, Munson PJ, Jones EA (1984c) Changes in glutamate receptors on synaptic membranes associated with hepatic encephalopathy or hyperammonemia in the rabbit. Hepatology 4: 25–29

    PubMed  CAS  Google Scholar 

  • Ferenci P, Ebner J, Zimmermann CH, Roth E, Häussinger D (1986a) Is blood gamma-amino- butyric acid (GABA) increased in hepatic encephalopathy? Hepatology 6: 1157

    Google Scholar 

  • Ferenci P, Jones EA, Hanbauer I (1986b) Lack of evidence for impaired dopamine receptor function in experimental hepatic encephalopathy. Neurosci Letters 65: 60–64

    CAS  Google Scholar 

  • Ferenci P, Zieve L, Ebner J, Zimmermann CH, Rzepczynski D (1986c) Postsynaptic neural membrane affinity for GABA and receptor density are unaltered in hepatic coma following portacaval shunt (PCS) and hepatic artery ligation ( HAL ). Hepatology 6: 1157

    Google Scholar 

  • Ferenci P, Zimmermann CH, Ebner J (1986d) Thioacetamide-induced acute liver failure in the rat - a suitable model for hepatic encephalopathy? J Hepatology 3, Suppl 1: 121

    Google Scholar 

  • Fischer JE, Baldessarini RJ (1971) False neurotransmitters and hepatic failure. Lancet 2: 75–80

    PubMed  CAS  Google Scholar 

  • Fischer JE, Funovics J, Aguirre A, James JH, Keane JH, Wesdorf RIC, Yoshimura N, Westman T (1975) The role of plasma amino acids in hepatic encephalopathy. Surgery 78: 276–290

    PubMed  CAS  Google Scholar 

  • Goetcheus JS, Webster LT (1965) 7-Aminobutyrate and hepatic coma. J Lab Clin Med 65:257– 267

    Google Scholar 

  • Gove CD, Ede RJ, Williams R (1984) In vivo reduction of Na+, K+-ATPase activity in rat brain during D-Galactosamine-induced acute hepatic failire: a possible cause of encephalopathy. In: Kleinberger G, Ferenci P, Riederer P, Thaler H (eds) Advances in hepatic encephalopathy and urea cycle diseases. Karger, Basel, pp 314–318

    Google Scholar 

  • Greenberger NJ, Carley J, Schenker S, Bettinger I, Stamnes C, Beyer P (1977) Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. Dig Dis 22: 845–855

    CAS  Google Scholar 

  • Grippon P, Le Poncin-Laffite M, Boschat M, Wang S, Favre G, Dutertre D, Opolon P (1986) Evidence for the role of ammonia in the intracerebral transfer and metabolism of tryptophan. Hepatology 6: 682–686

    PubMed  Google Scholar 

  • Hawkes CH, Macpherson AJS, Pryor H, Townsend HRA (1970) The values of EEG frequency analysis in hepatic encephalopathy. J Roy Coll Surg (Edingburgh) 18: 151–156

    Google Scholar 

  • Herlong GF, Maddrey WC, Walser M (1980) The use of ornithine salts of branched chain ketoacids in portal systemic encephalopathy. Ann Int Med 93: 545–550

    PubMed  CAS  Google Scholar 

  • Hindfelt B, Plum F, Duffy TE (1977) Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J Clin Invest 59: 386–396

    PubMed  CAS  Google Scholar 

  • Hirayama CH, Ichida F, Takahashi Y, Koizumi T, Sata S, Kosaka Y, Wakui K, Shimada Y, Yoshiba A, Hattori N, Ooya T, Takino T, Takeda H (1982) A controlled clinical trial of nicotino- hydroxamic acid and neomycin in advanced chronic liver disease. Digest 25: 115–123

    CAS  Google Scholar 

  • Holm E, Krämer W, Reith HJ, Magin T, Mezitis NHE (1977) Electrophysiological and psychometric studies in hepatic encephalopathy. In: Varro V, Balint GA, Creutzferdt W (eds) Current Views in Gastroenterology, vol I, Budapest, pp 597–613

    Google Scholar 

  • Horowitz ME, Schafer DF, Molnar P et al. (1983) Increased blood brain transfer in a rabbit model of acute liver failure. Gastroenterology 84: 1003–1011

    PubMed  CAS  Google Scholar 

  • Horst D, Grace ND, Conn HO et al. (1984) Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Heptology 4: 279–287

    CAS  Google Scholar 

  • Huet PM, Rocheleau B, Pomier-Layrargues G, Willems B (1984) Blood brain barrier in dogs with and without hepatic encephalopathy. In: Kleinberger G, Ferenci P, Riederer P, Thaler H (eds) Advances in hepatic encephalopathy and urea cycle diseases. Karger, Basel, pp 261–271

    Google Scholar 

  • James JH, Escourrou J, Fischer JE (1978) Blood brain neutral amino acid transport activity is increased after portacaval anastomosis. Science 200: 1395–1397

    PubMed  CAS  Google Scholar 

  • James JH et al. (1979) Hyperammonemia, plasma amino acid imbalance and blood-brain amino acid transport: a unified theory of portal-systemic encephalopathy. Lanced ii: 772–775

    Google Scholar 

  • Jones EA, Clain D, Clink HM, McGillivary M, Sherlock S (1967) Hepatic coma due to acute hepatic necrosis treated by exchange blood transfusions. Lancet 2: 169–171

    PubMed  CAS  Google Scholar 

  • Jonung T, Rigotti P, James JH, Brakcett K, Fischer JE (1985) Effect of hyperammonemia and methionine sulfoximine on the kinetic parameters of blood-brain transport of leucine and phenylalanine. J Neurochem 45: 308–317

    PubMed  CAS  Google Scholar 

  • Kienzl E, Riederer P, Jellinger K, Roth E, Ferenci P (1984) Modulation of serotonin receptors by L-value in hepatic encephalopathy. In: Schlossberger HG, Kochen W, Linzen B, Stein- hart H (eds) Progress in tryptophan and serotonin research. Walter de Gruyter amp; Co, Berlin New York, pp 333–337

    Google Scholar 

  • Lanthier PL, Morgan MY (1985) Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Gut 26: 415–420

    PubMed  CAS  Google Scholar 

  • Laursen H, Westergaard E (1977) Enhanced permeability to horseradish peroxidase across cerebral vessels in the rat after portacaval anastomosis. Neuropath Appl Neurobiol 3: 29–34

    Google Scholar 

  • Livingstone AS, Ptovin M, Goresky CA (1977) Changes in the blood brain barrier in hepatic coma after hepatectomy in the rat. Gastroenterology 73: 697–704

    PubMed  CAS  Google Scholar 

  • Lockwood AH, Ginsberg MD, Rhoades HM, Gutierrez MT (1986) Cerebral glucose metabolism after portacaval shunting in the rat. Pattern of metabolism and implications for the pathogenesis of hepatic encephalopathy. J of Clin Invest 78: 123–131

    Google Scholar 

  • Maddison JE, Dodd PR, Johnston GAR, Farrell GC (1987) Brain GABA receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma GABA-like activity. Gastroenterology 93: 1062–1068

    PubMed  CAS  Google Scholar 

  • Mans AM, Biebuyck JF, Saunders SJ, Kirseh RE, Hawkins RA (1979) Tryptophan transport across the blood-brain barrier during acute hepatic failure. J Neurochem 33: 409–418

    PubMed  CAS  Google Scholar 

  • Mans AM, Biebuyck JF, Shelly K, Hawkins RA (1982) Regional blood-brain barrier permeability to amino acids after portacaval anastomosis. J Neurochem 38: 705–717

    PubMed  CAS  Google Scholar 

  • Mans AM, Biebuyck JF, Davis DW, Bryan RM, Hawkins RA (1983) Regional cerebral glucose utilization in rats with portacaval anastomosis. J Neurochem 40: 986–991

    PubMed  CAS  Google Scholar 

  • McClain CJ, Zieve L, Doizaki WM, Gilbertstadt S, Onstad GR (1980) Blood methanethiol in alcoholic liver disease with and without hepatic encephalopathy. Gut 21: 318–323

    PubMed  CAS  Google Scholar 

  • McGillivary BB (1975) The EEG in liver disease. In: Glaser GH (ed) Metabolic, endocrine and toxic disease. Handbook of electroencephalogy and clinical neurophysiology, vol 15, part C Elsevier, Amsterdam, pp 5–26

    Google Scholar 

  • Mendenhall CL, Rouster S, Marshall L, Weesner R (1986) A new therapy for portal systemic encephalopathy. Amer J Gastroenterol 81: 540–543

    CAS  Google Scholar 

  • Meryn S, Bauman WA, Pappas SC, Ferenci P, Jones EA (1986) Brain cholecystokinin and vasoactive intestinal polypeptide: immunoreactivity in rabbits with hepatic coma. Liver 6: 281–285

    PubMed  CAS  Google Scholar 

  • Michel H, Solere M, Grainer P (1980) Treatment of cirrhotic hepatic encephalopathy with L-Dopa: a controlled trial. Gastroenterology 79: 207–211

    PubMed  CAS  Google Scholar 

  • Minuk GY, Winder A, Gurgess ED, Saijeant EJ (1985) Serum Gamma-aminobutyric acid ( GABA) levels in patients with hepatic encephalopathy. Hepato-gastroenterol 32: 171–174

    Google Scholar 

  • Morgan MY, Milson JP, Sherlock S (1978) Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut 19: 1068–1075

    PubMed  CAS  Google Scholar 

  • Morgan M, Jakobovitzs AW, James M, Sherlock S (1980) Successful use of bromoeriptine in the treatment of hepatic encephalopathy. Gastroenterology 78: 663–670

    PubMed  CAS  Google Scholar 

  • M’oni F, Lombardi G, Moneti G, Cortesini C (1983) The release and neosynthesis of glutamic acid are increased in experimental models of hepatic encephalopathy. J Neurochem 40: 850–854

    Google Scholar 

  • Moroni F, Riggio O, Carla V, Festuccia V, Ghinelli F, Varion IR, Merli M, Natali L, Pedretti G, Fiaccadori F, Capocaccia L (1987) Hepatic Encephalopathy: Lack of changes of 7-amino- butyric acid content in plasma and crebrospinal fluid. Hepatology 7: 816–820

    PubMed  CAS  Google Scholar 

  • Norenberg MD (1981) The astrocyte in liver disease. In: Fedoroff S, Hertz L (eds) Advances in cellular neurobiology, vol 2, Academic Press, pp 303–352

    Google Scholar 

  • Ono J, Hutson DG, Dombro RS, Levi JU, Livingstone A, Zeppa R (1978) Tryptophan and hepatic coma. Gastroenterology 74: 196–200

    PubMed  CAS  Google Scholar 

  • Opolon P (1984) Significance of middle molecules in the pathogenesis of hepatic encephalopathy. In: Kleinberger G, Ferenci P, Riederer P, Tahler H (eds) Advances in hepatic encephalopathy and urea cycle disease. Karger Verlag, Basel, pp 310–313

    Google Scholar 

  • Orlandi F, Freddara U. Candelaresi MT, Morettini A, Corazza GR, Di Simone A, Dobrilla G, Cavallini G (1981) Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy. Dig Dis Sci 26: 498–506

    Google Scholar 

  • Pappas SC, Ferenci P, Jones EA (1983a) Evidence against the hypothesis that cerebral edema in fulminant failure is due to decreased neural Na+, K+ ATPase activity. Hepatology 3: 848

    Google Scholar 

  • Pappas SC, Jones EA (1983b) Methods for assessing hepatic encephalopathy. Seminars in Liver Disease 3: 298–307

    PubMed  CAS  Google Scholar 

  • Pappas SC, Ferenci P, Schafer DF, Jones EA (1984a) Visual evoked potentials in a rabbit model of hepatic encephalopathy. II: Comparison of hyperamonemic encephalopathy, postictal coma, and coma induced by snyergistic neurotoxins. Gastroenterology 86: 546–551

    Google Scholar 

  • Pappas SC, Ferenci P, Jones EA (1984b) Hepatic Encephalopathy: a disorder of synaptic, plasma membrane composition and fluidity? In Kleinberger G, Ferenci P, Riederer P, Thaler H (eds) Advances in hepatic encephalopathy and urea cycle diseases, Karger Verlag Basel, pp 331–336

    Google Scholar 

  • Pappas SC, Levy GA, Gordon VP (1986) Decreased brain GABA binding in a model of fulminant hepatic failure (FHF): evidence conflicting with the GABA hypothesis for hepatic encephalopathy (HE). Hepatology 6:1106 Pardridge WH (1983) Brain metabolism: a perspective from the blood brain barrier. Physiol Rev 63: 1481–1535

    Google Scholar 

  • Parsons-Smith BG, Summerskill WHJ, Dawson AM, Sherlock S (1957) The electroencephalograph in liver disease. Lancet 2: 867–871

    Google Scholar 

  • Potvin M, Finlayson MH, Hinchey EJ, Lough JO, Goresky CA (1984) Cerebral abnormalities in hepatectomized rats with acute hepatic coma. Lab Invest 50: 560–564

    PubMed  CAS  Google Scholar 

  • Quarfoth G, Ahmed K, Zieve L (1976) Action of methane thiol on membrane Na+, K+-ATPase on rat brain. Biochem Pharmacol 25: 1039–1044

    Google Scholar 

  • Raabe W, Gumnit RJ (1975) Dishinibition in cat motor cortex by ammonia. J Neurophysiol 38: 437–455

    Google Scholar 

  • Rikkers L, Jenko P, Rudman D, Freides D (1978) Subclinical hepatic encephalopathy: Detection, prevalence and relationship to nitrogen metabolism. Gastroenterology 75: 462–469

    Google Scholar 

  • Rudman D, Galambos JT, Smith RB, Salam AA, Warren WD (1973) Comparison of the effect of various amino aacids upon blood ammonia concentrations of patients with liver disease. Amer J Clin Nutr 26: 916–925

    PubMed  CAS  Google Scholar 

  • Rzepczynski D, Zieve L, Lindblat S, LaFontaine D (1986) In vivo studies of GABAergic effects in experimental hepatic encephalopathy. Hepatology 6: 902–905

    PubMed  CAS  Google Scholar 

  • Samson Y, Bernuau J (1987) Cerebral uptake of benzodiazepine measured by positron emission tomography in hepatic encephalopathy. New Engl J Med 316:414 Sarna GS, Bradbury MW, Cavanagh J (1977) Permeability of the blood brain barrier after portacaval anastomosis in the rat. Brain Res 138: 550–554

    Google Scholar 

  • Sarna GS, Bradbury MWB, Cremer JE, Lai JCK, Teal HM (1979) Brain metabolism and specific transport at the blood brain barrier after portocaval anastomosis in the rat. Brain Res 160: 69–83

    PubMed  CAS  Google Scholar 

  • Schafer DF, Fowler JM, Jones EA (1981) Colonic Bacteria: a source of 7-aminobutyric acid in blood (41169). Proc Soc Exp Biol Med 167: 301–303

    PubMed  CAS  Google Scholar 

  • Schafer DF, Jones EA (1982) Hepatic encephalopathy and the 7-aminobutyric acid neurotransmitter system. Lancet 2: 18–19

    Google Scholar 

  • Schafer DF, Fowler JM, Munson PJ (1983) Gamma-aminobutyric acid and benzodiazepin receptors in an animal model of fulminant hepatic failure. J Lab Clin Med 102: 870–880

    PubMed  CAS  Google Scholar 

  • Schafer DF, Pappas SC, Brady LE, Jacobs R, Jones EA (1984) Visual evoked potentials in a rabbit model of hepatic encephalopathy. I: Sequential changes and comparisons with drug induced comas. Gastroenterology 86: 540–545

    Google Scholar 

  • Schalm SW, Van der Mey T (1979) Hyperammonemic coma after hepatectomy in germ-free rats. Gastroenterology 77: 231–234

    PubMed  CAS  Google Scholar 

  • Schomerus H, Hamster W, Blunck H, Reinhard U, Mayer K, Dolle W (1981) Latent portasystemic encephalopathy I. Nature of cerebral functional defects and fitness to drive. Dig Dis Sci 26: 622–630

    Google Scholar 

  • Scollo-Lavizzari G, Steinman E (1985) Reversal of hepatic coma by benzodiazepin antagonist (Ro 15–1788). Lancet 1: 1324

    Google Scholar 

  • Seda HWM, Hughes RD, Gove CD, Williams R (1984) Inhibition of rat brain Na+, K+-ATPase activity by serum from patients with fulminant hepatic failure. Hepatology 4: 74–79

    Google Scholar 

  • Shaw S, Worner TM Lieber CS (1983) Comparison of animal and vegetable protein sources in the dietary management of hepatic encephalopathy. Amer J Clin Nutr 38: 59–63

    Google Scholar 

  • Stahl J (1963) Studies of the blood amonia in liver disease. Its diagnostic, prognostic and therapeutic significance. Ann Int Med 58: 1–24

    PubMed  CAS  Google Scholar 

  • Tangerman A, Meuwese-Arends MT, Van Tongeren JHM (1983) A new sensitive assay for measuring volatile sulphur compounds in human breath by tenax trapping and gas chromatography and its application in liver cirrhosis. Clin Chim Acta 130: 103–110

    PubMed  CAS  Google Scholar 

  • Traber PG, Ganger DR, Blei AT (1986) Brain edema in rabbits with galactosamine induced fulminant hepatitis. Regional differences and effects on intracranial pressure. Gastroenterology 91: 1347–1356

    Google Scholar 

  • Uribe M (1986) Optimized treatment options in portal systemic encephalopathy. Proc IASL Postgraduate course: Recent advances in hepatology, caracas Uribe M, Farca A, Marquez MA et al. (1979) Treatment of chronic portal systemic encephalopathy

    Google Scholar 

  • with bromocriptine. Gastroenterology 76:1347–1351

    Google Scholar 

  • Uribe M, Marquez MA, Gargaramos et al. (1980) Treatment of chronic portal systemic encephalopathy with lactose in lactase deficient patients. Dig Dis Sci 25: 914–928

    Google Scholar 

  • Uribe M, Marquez MA, Ramos GG, Ramos-Uribe MH, Vargas F, Villalobos A, Ramos C (1982) Treatment of chronic portal-systemic encephalopathy with vegetable and animal protein diets. Dig Dis Sci 27: 1109–1116

    PubMed  CAS  Google Scholar 

  • Van der Ryt CCd, Schalm SW, De Groot GH, De Vlieger M (1984) Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalography and Clin Neurophysiology 57: 423–426

    Google Scholar 

  • Weber FL, Veach GL (1979) The importance of the small intestine in gut ammonia production in germ free rats. Gastroenterology 77: 235–240

    PubMed  Google Scholar 

  • Weber FL, Minco D, Fresard KM, Banwell JG (1985) Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects. Gastroenterology 89: 538–544

    PubMed  CAS  Google Scholar 

  • Windus-Podehl G, Lyftogt L, Zieve L (1983) Encephalopathic effect of phenol in rats. J Lab Clin Med 101: 586–592

    PubMed  CAS  Google Scholar 

  • Yang SS, Chu NS, Liaw YF (1985) Somatosensory evoked potentials in hepatic encephalopathy. Gastroenterology 89:625–630 Yang SS, Chu NS, Liaw YF (1986) Brainstem auditory evoked potentials in hepatic encephalopathy. Heptalogy 6: 1352–1355

    Google Scholar 

  • Zaki AEO, Wardle EN, Canalese J et al. (1983) Potential toxins of acute liver failure and their

    Google Scholar 

  • effects on blood-brain-barrier permeability. Experientia 39:988–991

    Google Scholar 

  • Zaki AEO, Ede RJ, Davis M, Williams R (1984) Experimental studies of blood brain barrier permeabolity in acute hepatic failure. Hepatology 4: 359–363

    PubMed  CAS  Google Scholar 

  • Zeneroli ML, Iuliano E, Racagni G, Baraldi M (1982a) Metabolism and brain uptake of gamma- aminobutyric acid in galactosamine-induced hepatic encephalopathy in rats. J Neurochem 38: 1219–1222

    PubMed  CAS  Google Scholar 

  • Zeneroli ML, Ventura E, Baraldi M, Penne A, Messori E, Zieve L (1982b) Visual evoked potentials in encephalopathy induced by galactosamine, ammonia, dimethyl, disulfied and octanoic acid. Hepatology 2: 532–538

    PubMed  CAS  Google Scholar 

  • Zeneroli ML, Pinelli G, Gollini G, Penne A, Messori E, Zani G, Ventura E (1984) Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalpathy. Gut 25: 291–299

    PubMed  CAS  Google Scholar 

  • Zeneroli ML, Ventura E, Pinelli G, Casciarri I, Germini M, Cavalletti E, Tofanetti O, Baraldi M (1985) Opiate receptors and -endorphin levels in brain areas of dogs with portal-systemic encephalopathy. J Hepatol 1: 619–627

    PubMed  CAS  Google Scholar 

  • Zieve L, Olsen EL (1977) Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine? Gut 18: 688–691

    PubMed  CAS  Google Scholar 

  • Zieve L, Doizaki WM, Zieve FJ (1974) Synergism between mercaptanes and ammonia or fatty acids in the production of coma: a possible role for mercaptanes in the pathogenesis of hepatic coma. J Lab Clin Med 83: 16–28

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Gastroenterologie und Hepatologie, Universität Wien, Lazarettgasse 14, A-1090, Wien, Austria

    P. Ferenci

Authors
  1. P. Ferenci
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

P. Frick G.-A. von Harnack K. Kochsiek G. A. Martini A. Prader

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Ferenci, P. (1998). Hepatische Enzephalopathie. In: Frick, P., von Harnack, GA., Kochsiek, K., Martini, G.A., Prader, A. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde/Advances in Internal Medicine and Pediatrics. Ergebnisse der Inneren Medizin und Kinderheilkunde/Advances in Internal Medicine and Pediatrics, vol 57. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73558-5_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73558-5_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73559-2

  • Online ISBN: 978-3-642-73558-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation